Juan J. Russo et al. JACC 2019;73:

Slides:

Advertisements

Similar presentations

Slide Source: Lipids Online Slide Library Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) 5804 patients aged 70–82.

Advertisements

Rimoldi SF et al. J Clin Hypertens (Greenwich). 2015;17(3): Efficacy and safety of calcium channel blocker/diuretics combination therapy in hypertensive.

Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.

Canadian Diabetes Association Clinical Practice Guidelines Management of Stroke in Diabetes Chapter 27 Michael Sharma, Gord Gubitz.

Warfarin Dabigatran Rivaroxaban Apixaban Edoxaban Target

Supervisor: Vs 余垣斌 Presenter: CR 周益聖. INTRODUCTION.

CHARM-Alternative: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Alternative Purpose To determine whether the angiotensin.

CHARM-Preserved: Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity - Preserved Purpose To determine whether the angiotensin.

Randomized, double-blind, multicenter, controlled trial.

ACTIVE Clopidogrel plus Aspirin versus Aspirin in Patients Unsuitable for Warfarin.

Sunil V. Rao MD The Duke Clinical Research Institute The Durham VA Medical Center Duke University Medical Center Transradial PCI in Octogenarians: Caveats,

PARTNER Objective To compare surgical aortic valve replacement (AVR) with transcatheter aortic valve replacement (TAVR) in high-risk patients with severe.

Ihab Alomari, MD, FACC Assistant professor – Interventional Cardiology University of California, Irvine Division of Cardiology Cath Lab Essentials : LV.

COPERNICUS: Carvedilol Prospective Randomized Cumulative Survival trial Purpose To assess the effect of carvedilol, a β 1 -, β 2 - and α 1 -receptor blocker,

Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.

Date of download: 7/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Choice of Antithrombotic Therapy for Stroke Prevention.

Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.

Management of Cardiogenic Shock in AMI

Revascularization in Patients With Left Ventricular Dysfunction:

From: Risk–Benefit Profile of Long-Term Dual- Versus Single-Antiplatelet Therapy Among Patients With Ischemic StrokeA Systematic Review and Meta-analysis.

Nat. Rev. Cardiol. doi: /nrcardio

SOCRATES Trial design: Patients with acute ischemic stroke were randomized in a 1:1 fashion to receive either ticagrelor 180 mg load + 90 mg BID or aspirin.

Risk of Stroke or Death Is Associated With the Timing of Carotid Artery Stenting for Symptomatic Carotid Stenosis: A Secondary Data Analysis of the German.

Iatrogenic Adverse Events in the Coronary Care Unit

Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.

RE-CIRCUIT Trial design: Patients with atrial fibrillation undergoing catheter ablation were randomized to uninterrupted dabigatran 150 mg twice daily.

The Use of Impella for CGS Patients Does It Save Lives?

EUCLID Trial design: Patients with peripheral arterial disease (PAD) were randomized to ticagrelor 90 mg twice daily (n = 6,930) vs. clopidogrel 75 mg.

Panelists. Secondary Prevention of Acute Ischemic Stroke: Can We Improve Outcomes?

Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke David Pereg, MD, Zach Rozenbaum, MD, Dina Vorobeichik, MA, Nir Shlomo,

INOVATE-HF Trial design: Patients with heart failure (HF) were randomized to device implant for vagus nerve stimulation (n = 436) versus optimal medical.

Lars A. Dejgaard et al. JACC 2018;72:

Left atrial appendage closure: A new technique for clinical practice

ANTARCTIC Trial design: Patients with acute coronary syndrome undergoing stenting were randomized to tailored antiplatelet therapy (n = 435) versus conventional.

Dean J. Kereiakes et al. JACC 2017;70:

chemotherapy for patients with MC versus those with AC

Mechanical Circulatory Support Devices HOSEIN PASANDI.

David D. Berg et al. JACC 2018;71:

Risk of perioperative renal dysfunction with N-acetylcysteine or placebo in patients undergoing CABG surgery End point N-acetylcysteine Placebo Relative.

NIPPON Trial design: Patients undergoing percutaneous coronary intervention were randomized to short-term dual antiplatelet therapy (DAPT) (6 months; n.

End point Fenoldopam, n (%) Dopamine, n (%) p

Hong-Tao Tie, MD, Rui Shi, MD The American Journal of Medicine

Juan J. Russo et al. JACC 2019;73:

Isla M. Ogilvie, PhD, Nick Newton, PhD, Sharon A

David J.A. Jenkins et al. JACC 2018;71:

David J.A. Jenkins et al. JACC 2018;71:

Mahesh Anantha Narayanan et al. JACEP 2017;3:

Potential mechanisms whereby statins may reduce the risk of stroke

Final CM for the early HTA of current and novel heart valve interventions. Final CM for the early HTA of current and novel heart valve interventions. Cerebrovascular.

Jerry D. Estep et al. JCHF 2013;1:

Mintu P. Turakhia et al. JACEP 2016;2:

Emilce Trucco et al. JACEP 2018;j.jacep

Behnam N. Tehrani et al. JACC 2019;73:

Canadian Cardiovascular Society Atrial Fibrillation Guidelines 2010: Prevention of Stroke and Systemic Thromboembolism in Atrial Fibrillation and Flutter

IMPRESS Trial design: Patients undergoing primary PCI for STEMI and cardiogenic shock were randomized in a 1:1 to either Impella CP or IABP. They were.

(p for noninferiority = 0.01)

Giuseppe Gargiulo et al. JACC 2018;71:

Nikole J. Byrne et al. BTS 2017;j.jacbts

Long-term Outcomes of Carotid Endarterectomy Versus Stenting: A 12-Year Multicenter Observational Analysis of 14,464 Patients Mohamad A. Hussain, Muhammad.

Figure 1 Stacked bar chart depicts the proportion of patients with diffusion-weighted imaging (DWI)+ and DWI− scans categorized by index event type TIA.

Jeffrey J. Teuteberg et al. JCHF 2015;3:

Zachary L. Steinberg et al. JACC 2017;69:

Zachary L. Steinberg et al. JACC 2017;69:

Maxime Berthelot-Richer et al. JIMG 2016;9:

Comparison of dual antiplatelet versus monotherapy in acute ischaemic stroke or transient ischaemic attack on major bleeding. A, aspirin; C, clopidogrel;

David J.A. Jenkins et al. JACC 2018;71:

David J.A. Jenkins et al. JACC 2018;71:

Gianluigi Savarese et al. JCHF 2016;4:

The CHA(2)DS2-(VASc) stroke risk and HAS-BLED bleeding risk index are calculated by totalling the scores for each risk factor present.68–71 The lower graph.

Presentation transcript:

Juan J. Russo et al. JACC 2019;73:654-662 Secondary Outcomes in Relation to Left Ventricular Unloading During VA-ECMO The association between left ventricular unloading during VA-ECMO for cardiogenic shock and secondary outcomes was assessed using a random effects model. Left ventricular unloading during VA-ECMO for cardiogenic shock was associated with increased rates of hemolysis (RR: 2.15; 95% CI: 1.49 to 3.11; p < 0.0001). The rate of bleeding, limb ischemia, renal replacement therapy, multiorgan failure, and stroke or transient ischemic attack were similar between patients treated with VA-ECMO with versus without left ventricular unloading. TIA = transient ischemic attack; other abbreviations as in Figures 1 and 3. Juan J. Russo et al. JACC 2019;73:654-662 2019 The Authors